Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of demographics and socioeconomic status on the receipt of immunotherapy for stage III melanoma.

Surgical oncology·2024
Same author

Safety and Feasibility of Single-Port Robotic-Assisted Nipple-Sparing Mastectomy.

JAMA surgery·2024
Same author

Educational Experience Impacts Wellness More than Hours Worked.

Journal of surgical education·2022
Same author

Laparoscopic Ambidexterity in Left-Handed Trainees.

The Journal of surgical research·2022
Same author

Erector spinae plane block versus thoracic paravertebral block for pain management after total bilateral mastectomies.

Proceedings (Baylor University. Medical Center)·2021
Same author

Creating a Proficiency-based Remote Laparoscopic Skills Curriculum for the COVID-19 Era.

Journal of surgical education·2021
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Minimally Invasive and Robotic Surgery for Breast Cancer.

Paige A Blinn1, Brendan Sayers1, Deborah E Farr1

  • 1Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Surgical Oncology Clinics of North America
|June 9, 2026
PubMed
Summary
This summary is machine-generated.

Minimally invasive mastectomy offers benefits like better visualization and patient satisfaction. While the robotic nipple-sparing mastectomy (rNSM) is safe for selected patients, long-term oncologic safety requires further research.

Keywords:
Breast cancerCancerNipple sparing mastectomyRobotic surgery

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Related Experiment Videos

Last Updated: Jun 11, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Area of Science:

  • Oncology
  • Surgical Innovation

Background:

  • Breast cancer is a leading cause of death in women globally.
  • Minimally invasive mastectomy techniques aim to improve patient outcomes and satisfaction.
  • Enhanced visualization and comparable oncologic results are potential benefits of these approaches.

Purpose of the Study:

  • To evaluate the safety and feasibility of robotic nipple-sparing mastectomy (rNSM).
  • To compare oncological outcomes of minimally invasive mastectomy with open procedures.
  • To assess patient-reported satisfaction with minimally invasive mastectomy.

Main Methods:

  • Review of peri-operative and oncological outcomes for rNSM.
  • Comparison of outcomes between rNSM and traditional open mastectomy.
  • Assessment of patient-reported satisfaction metrics.

Main Results:

  • Minimally invasive mastectomy demonstrates potential benefits, including enhanced visualization.
  • Patient-reported satisfaction is improved with minimally invasive approaches.
  • Peri-operative and oncological outcomes are comparable to open procedures.

Conclusions:

  • Robotic nipple-sparing mastectomy (rNSM) is a safe and feasible option for carefully selected breast cancer patients.
  • Further investigation is necessary to confirm the long-term oncologic safety of rNSM.